Pharma Reviews: Alniche launches novel product in collaboration with DPSRU

“This launch will mark a beginning of Indian Pharma industry focusing on introducing products that are suited for Indian masses. He also expressed ...
Read more: Alniche launches novel product in collaboration with DPSRU

Pharma Reviews: Dangerous drugs, compromised regulators

The role Indian companies played from the 1990s onwards in the ... Indian companies also make active ingredients for drug manufacturers in other ...
Read more: Dangerous drugs, compromised regulators

Pharma Reviews: Alniche Launched Novel Product in Collaboration With DPSRU

Alniche Life Sciences is a Delhi based PAN India specialty healthcare company focused on serving patients and the medical fraternity by offering ...
Read more: Alniche Launched Novel Product in Collaboration With DPSRU

Pharma Reviews: India wants to become a very significant player in the global supply chain of pharmaceuticals: Dr ...

If you look at supply chain in the pharmaceutical industry it starts right from the raw materials procurement-to testing of materials, getting it ...
Read more: India wants to become a very significant player in the global supply chain of pharmaceuticals: Dr ...

Pharma Reviews: Mylan deal to give a boost to Pfizer's India business: Analysts

Mylan, through its acquisition of Matrix Pharma, has several products in ... billion Indian pharma market, according to figures from AWACS, a pharma ...
Read more: Mylan deal to give a boost to Pfizer's India business: Analysts

Pharma Reviews: Alniche launches novel product in collaboration with DPSRU

"This launch will mark a beginning of Indian Pharma industry focusing on introducing products that are suited for Indian masses. He also expressed ...
Read more: Alniche launches novel product in collaboration with DPSRU

Pharma Reviews: Alniche Launched Novel Product in Collaboration With DPSRU

New Delhi, Delhi, India – Business Wire India ... that this launch will mark a beginning of Indian Pharma industry focusing on introducing products that ...
Read more: Alniche Launched Novel Product in Collaboration With DPSRU

Pharma Reviews: Alniche Launched Novel Product in Collaboration With DPSRU

Delhi Pharmaceutical Sciences and Research University (DPSRU), is the first Pharmacy University of India, as a Delhi State University. The vision of ...
Read more: Alniche Launched Novel Product in Collaboration With DPSRU

US FDA News: FDA clears new indications for existing Lyme disease tests that may help streamline diagnoses

FDA clears new indications for existing Lyme disease tests that may help streamline diagnoses
Read more: FDA clears new indications for existing Lyme disease tests that may help streamline diagnoses

Pharma Reviews: Strides inks JV pact with China's Sihuan Pharma

The JV pact was inked between Indian firm's step-down subsidiary Strides Pharma Global Pte, Singapore(SPG) and Sun Moral International (HK) ...
Read more: Strides inks JV pact with China's Sihuan Pharma

Pharma Reviews: Indian drug makers scouting for partners in China: report

Amid stifling competition in its biggest market, the US, Indian drug makers are scouting for partners in China, the world's second largest drug market.
Read more: Indian drug makers scouting for partners in China: report

Pharma Reviews: Indian drug makers scouting for partners in China: report

Amid stifling competition in its biggest market, the US, Indian drug makers are scouting for partners in China, world's second largest drug market.
Read more: Indian drug makers scouting for partners in China: report

Pharma Reviews: Out of 129 stocks, 4 rose more than 100% in which FIIs raised stake in last 4 quarters

“The Indian equity market is witnessing net FIIs outflows due to domestic ... On the other hand, the beaten-down auto and pharma sector may also ...
Read more: Out of 129 stocks, 4 rose more than 100% in which FIIs raised stake in last 4 quarters

Pharma Reviews: Stock pick of the week: Jubilant Life Sciences offers long-term growth say analysts

Warning letters from the US Food and Drug Administration (FDA) to Indian pharmaceuticals companies have led to sharp price corrections in these ...
Read more: Stock pick of the week: Jubilant Life Sciences offers long-term growth say analysts

Pharma Reviews: This week in Pharma: Potential Pfizer-Mylan deal could begin consolidation of generic industry

The merger will have implications on Indian pharmaceutical companies as well. Much of Mylan's manufacturing infrastructure is based in India.
Read more: This week in Pharma: Potential Pfizer-Mylan deal could begin consolidation of generic industry

Pharma Reviews: Alniche launched Novel Product In Collaboration With DPSRU

... Mr Girish Arora (Founder & Managing Director, Alniche Lifesciences) said, that this launch will mark a beginning of Indian Pharma industry focusing ...
Read more: Alniche launched Novel Product In Collaboration With DPSRU

Product Recall Alerts: Parkinson's, epilepsy drugs recalled due to 'risk of patient safety'

The medicines recalled at pharmacy level include: ... Following new information, we have issued this further alert to ensure pharmacies have the ...
Read more: Parkinson's, epilepsy drugs recalled due to 'risk of patient safety'

Product Recall Alerts: More batches of Vimpat 100mg tablets recalled by MHRA

More batches of the epilepsy medication Vimpat (lacosamide) 100mg ... Please refer to the MHRA alert for further information on the batches affected.
Read more: More batches of Vimpat 100mg tablets recalled by MHRA

Pharma Reviews: Cheaper versions of blockbuster diabetic drug to hit mkt soon

Industry watchers say most companies are keen to launch the drug, including ... What makes the patent expiry significant for Indian pharma is that ...
Read more: Cheaper versions of blockbuster diabetic drug to hit mkt soon

US FDA News: Xeljanz, Xeljanz XR (tofacitinib): Drug Safety Communication - Due to an Increased Risk of Blood Clots and Death with Higher Dose

Drug Safety Communication - Due to an Increased Risk of Blood Clots and Death with Higher Dose
Read more: Xeljanz, Xeljanz XR (tofacitinib): Drug Safety Communication - Due to an Increased Risk of Blood Clots and Death with Higher Dose

Product Recall Alerts: Drug regulator recalls drugs for epilepsy and Parkinson's

The Medicines and Healthcare products Regulatory Agency (MHRA) issued an alert yesterday over some batches of the medicine which are being ...
Read more: Drug regulator recalls drugs for epilepsy and Parkinson's

Pharma Reviews: DSP's Gopal Agarwal on why he has bought into market correction

In terms of the pharma sector valuation, it has derated materially because of issues in US business. We are still seeing 8-10% top line growth in India.
Read more: DSP's Gopal Agarwal on why he has bought into market correction

Pharma Reviews: Ranbaxy Why cutting corners didn't work

In this context, the book notes that the endorsement in November 2013 of Ranbaxy and other Indian pharma companies by former US President Bill ...
Read more: Ranbaxy Why cutting corners didn't work

Pharma Reviews: After 17-fold returns in 10 years, can Torrent Pharma continue its marathon run?

Indian pharmaceutical sector has been in the doldrums recently with Nifty Pharma tumbling about 10.7 percent so far in 2019. The sector has been in ...
Read more: After 17-fold returns in 10 years, can Torrent Pharma continue its marathon run?

Pharma Reviews: A hypertension drug ingredient put patients at risk of cancer. The world is alarmed. Not India.

Indian pharma companies have used that ingredient from the same supplier. ... Since the impurities in valsartan manufacturing affected several drug ...
Read more: A hypertension drug ingredient put patients at risk of cancer. The world is alarmed. Not India.

Product Recall Alerts: Officials recall MORE batches of two drugs for Parkinson's and epilepsy amid fears they were ...

Previous versions of the same medications which were recalled had labels ... 'Following new information, we have issued this further alert to ensure ...
Read more: Officials recall MORE batches of two drugs for Parkinson's and epilepsy amid fears they were ...

Product Recall Alerts: Parkinson's and epilepsy medication recalled due to possible health risk - full items list

Parkinson's and epilepsy medication recalled due to possible health risk - full ... Following new information, we have issued this further alert to ensure ...
Read more: Parkinson's and epilepsy medication recalled due to possible health risk - full items list

Product Recall Alerts: Parkinson's and epilepsy patients urged to check medication amid drugs recall

Patients with Parkinson's and epilepsy are being urged to check their medications after a number of batches were recalled. Batches of the ...
Read more: Parkinson's and epilepsy patients urged to check medication amid drugs recall

Product Recall Alerts: Breast implants from Irish-headquartered company recalled due to cancer risk

Allergan breast implants have been recalled by the US Food and Drug ... the FDA took action to alert the firm to new evidence indicating a recall is ...
Read more: Breast implants from Irish-headquartered company recalled due to cancer risk

Pharma Reviews: Mega diabetes drug to be cheaper soon

Industry watchers say most companies, including Zydus Cadila, Glenmark, ... What makes the patent expiry significant for Indian pharma is that ...
Read more: Mega diabetes drug to be cheaper soon

Pharma Reviews: Purity norms drive nanotech in pharma

In a shabby lane of Noida's sector 2, a non-descript building houses the India offices of a clever little company. Arcanely named i3 Nanotec, it has ...
Read more: Purity norms drive nanotech in pharma

Pharma Reviews: New Formula

Zydus Cadila, India's fourth-largest drug company by revenue, is banking big on research of new drugs, even though others have bowed out.
Read more: New Formula

Pharma Reviews: Torrent Pharma delivers steady Q1, all eyes on India market recovery

Mumbai: Shares of Torrent Pharmaceuticals Ltd gained nearly 10% on Wednesday after the company impressed the Street with a steady performance ...
Read more: Torrent Pharma delivers steady Q1, all eyes on India market recovery

US FDA News: FDA approves first treatment for severe hypoglycemia that can be administered without an injection

FDA approves Baqsimi nasal powder, the first glucagon therapy for the emergency treatment of severe hypoglycemia that can be administered without an injection.
Read more: FDA approves first treatment for severe hypoglycemia that can be administered without an injection

US FDA News: FDA takes action to protect patients from risk of certain textured breast implants; requests Allergan voluntarily recall certain breast implants and tissue expanders from market

FDA takes action to protect patients from risk of certain textured breast implants; requests Allergan voluntarily recall certain breast implants and tissue expanders from market
Read more: FDA takes action to protect patients from risk of certain textured breast implants; requests Allergan voluntarily recall certain breast implants and tissue expanders from market

Pharma Reviews: Diverse Infotech Embraces Digital Manufacturing for 4.0 Indian Enterprises

Some of the most impacted industries with digital transformation in manufacturing are the automobile industry, the pharma industry and the telecom ...
Read more: Diverse Infotech Embraces Digital Manufacturing for 4.0 Indian Enterprises

US FDA News: FDA warns company marketing unapproved cannabidiol products with unsubstantiated claims to treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety

FDA has issued a warning letter to Curaleaf Inc. for illegally selling unapproved cannabidiol products online with unsubstantiated claims that the products treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety, among other conditions or diseases.
Read more: FDA warns company marketing unapproved cannabidiol products with unsubstantiated claims to treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety

Pharma Reviews: Worst is over for the pharma sector. What investors should do

Steps taken by the Indian pharmaceutical companies to reduce their costs should improve earnings growth. “Indian pharma companies have learned ...
Read more: Worst is over for the pharma sector. What investors should do

US FDA News: FDA suspends facility registration of Texas-based seafood producer after significant, repeated food safety violations

FDA suspends facility registration of Texas-based seafood producer
Read more: FDA suspends facility registration of Texas-based seafood producer after significant, repeated food safety violations

US FDA News: FDA approves first generics of Lyrica

FDA approves first generics of Lyrica (pregabalin)
Read more: FDA approves first generics of Lyrica

US FDA News: FDA launches its first youth e-cigarette prevention TV ads, plans new educational resources as agency approaches one-year anniversary of public education campaign

FDA is launching its first youth e-cigarette prevention TV ads and is planning to provide new educational resources as agency approaches one-year anniversary of public education campaign.
Read more: FDA launches its first youth e-cigarette prevention TV ads, plans new educational resources as agency approaches one-year anniversary of public education campaign

Pharma Reviews: How to get filthy rich in rising Asia

Indian pharma companies have played an important role in the global ... deceit and implosion of Ranbaxy, once the success story of Indian pharma.
Read more: How to get filthy rich in rising Asia

Pharma Reviews: Govt to list 'essential medical devices', cap trade margin

Indian Council of Medical Research – the research and analysis wing of ... overseas manufacturer's first point of sale at which their goods enter India ...
Read more: Govt to list 'essential medical devices', cap trade margin

Pharma Reviews: China asks New Delhi to joint fight against unilateralism, protectionism amid trade war with US

India for long has been pressing China to open its pharmaceutical market for ... He said latest figures show that China's imports of Indian goods grew by 15 per ... India wants foreign companies to store data locally and announced a ...
Read more: China asks New Delhi to joint fight against unilateralism, protectionism amid trade war with US

Pharma Reviews: China asks New Delhi to joint fight against unilateralism, protectionism amid trade war with US

India for long has been pressing China to open its pharmaceutical market for Indian pharma exports to address the yawning trade deficit which last ...
Read more: China asks New Delhi to joint fight against unilateralism, protectionism amid trade war with US

Pharma Reviews: Bottle of Lies, Cabinet of Neglect

The FDA has issued 209 warning letters so far, of which nine are to Indian Pharma companies, versus eight out of 419 in 2018. It is, of course, possible ...
Read more: Bottle of Lies, Cabinet of Neglect

Pharma Reviews: Ajanta Pharma bets on India, US markets to beat African tenders slowdown

Ajanta Pharma was the first generic company in anti-malaria institutional ... generics in India and other emerging markets," said Yogesh M. Agrawal, ...
Read more: Ajanta Pharma bets on India, US markets to beat African tenders slowdown

Pharma Reviews: US-China trade war: Why China's loss hasn't been India's gain

For the first time in nine months, India's exports shrank 9.71% last month to $25.01 ... pharma, electronic goods and jute manufacturing, observed Federation of ... The industry body further stated that barring these 9 major product ...
Read more: US-China trade war: Why China's loss hasn't been India's gain

Pharma Reviews: Fossil Remedies opens new PCD Pharma Franchise Business Program

Indian firm Fossil Remedies, which is a manufacturer and marketer of pharmaceutical products in the healthcare industry, has announced the ...
Read more: Fossil Remedies opens new PCD Pharma Franchise Business Program

US FDA News: Federal judge enters consent decree against Arkansas food and medical product grocery warehouse for insanitary conditions

A federal court ordered an Arkansas company to stop distributing food, drug products, medical devices and cosmetics until the company complies with the Federal Food, Drug, and Cosmetic Act (FD&C Act) and other requirements listed in a consent decree.
Read more: Federal judge enters consent decree against Arkansas food and medical product grocery warehouse for insanitary conditions

US FDA News: FDA launches public education campaign to encourage safe removal of unused opioid pain medicines from homes

“Remove the Risk” to raise awareness about proper disposal of prescription opioids
Read more: FDA launches public education campaign to encourage safe removal of unused opioid pain medicines from homes

US FDA News: Statement by Douglas Throckmorton, M.D., Deputy Center Director for Regulatory Programs in FDA’s Center for Drug Evaluation and Research, on new opioid analgesic labeling changes to give providers better information for how to properly taper patients who are physically dependent on opioids

Agency issued a drug safety communication to make doctors and patients aware of the labeling changes and the need for careful tapering to avoid side effects
Read more: Statement by Douglas Throckmorton, M.D., Deputy Center Director for Regulatory Programs in FDA’s Center for Drug Evaluation and Research, on new opioid analgesic labeling changes to give providers better information for how to properly taper patients who are physically dependent on opioids

Pharma Reviews: Indian pharma is not sub-par, it is ensuring the world doesn't face a healthcare crisis

It's very important for people to know that global healthcare has benefited hugely from the Indian pharmaceutical industry, and from generic drugs that ...
Read more: Indian pharma is not sub-par, it is ensuring the world doesn't face a healthcare crisis

Pharma Reviews: Cabinet okays Rs 330 crore loan to 3 pharma PSUs for clearing staff liabilities

Cabinet okays Rs 330 crore loan to 3 pharma PSUs for clearing staff ... of Rs 330.35 crore to three state-owned pharma companies to help them clear ... for meeting the employees' liabilities of Indian Drugs & Pharmaceuticals Ltd ...
Read more: Cabinet okays Rs 330 crore loan to 3 pharma PSUs for clearing staff liabilities

Pharma Reviews: US FDA Raises Doubts About Indian Pharma Company's Quality Control Practices

The FDA found “significant violations” of current good manufacturing practice (CGMP) regulations at Strides Pharma's plant in Puducherry in southern ...
Read more: US FDA Raises Doubts About Indian Pharma Company's Quality Control Practices

Pharma Reviews: Indian Pharma Expo 2019: 150 Pharma Companies participating

A three days long Indian Pharma Expo 2019 was inaugurated today by Dr. Monica Sood Bhatia, Managing Director, CIMS Medica, Mr. DC Sahu, ...
Read more: Indian Pharma Expo 2019: 150 Pharma Companies participating

Pharma Reviews: Pharma firms troubled by US FDA warning letters; data integrity issues worry industry, investors

For Indian pharmaceutical manufacturers, 2019 has so far been a difficult year as many are finding it tough to comply with US Food and Drug ...
Read more: Pharma firms troubled by US FDA warning letters; data integrity issues worry industry, investors

Pharma Reviews: US FDA finds "significant violations" at India's Strides plant

The US Food and Drug Administration (FDA) said it found adulteration and "significant violations" of current good manufacturing practice (CGMP) ...
Read more: US FDA finds "significant violations" at India's Strides plant

Pharma Reviews: AI will replace low-level healthcare roles: Rituparna Chakraborty, ISF

In the Indian healthcare and pharma sector, flexi staffing has grown by 8% ... Q. How do you see the impact on jobs in the healthcare sector of India?
Read more: AI will replace low-level healthcare roles: Rituparna Chakraborty, ISF

US FDA News: FDA approves new treatment for complicated urinary tract and complicated intra-abdominal infections

FDA approved Recarbrio, an antibacterial drug to treat adults with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI).
Read more: FDA approves new treatment for complicated urinary tract and complicated intra-abdominal infections

Pharma Reviews: India's Pharma Market Grows At Slowest Pace In Five Years

India's pharmaceutical market grew at its slowest pace in five years in the quarter ended June because of a fall in volumes even as prices remained ...
Read more: India's Pharma Market Grows At Slowest Pace In Five Years

Pharma Reviews: Closing Bell: Sensex ends above 39100, Nifty at 11662, midcaps outperform, Yes Bank jumps 14 ...

Indian equity benchmark indices, BSE Sensex and NSE Nifty50, ended with gains after ..... Indian pharma market grew 8.8 percent YoY in June 2019.
Read more: Closing Bell: Sensex ends above 39100, Nifty at 11662, midcaps outperform, Yes Bank jumps 14 ...

Pharma Reviews: CLSA expects pharma market to grow 10-12% in FY20

Indian pharma market grew 8.8 percent YoY in June 2019. With high single-digit growth in five out of six months of CY19, growth on a TTM (Trailing 12 ...
Read more: CLSA expects pharma market to grow 10-12% in FY20

Pharma Reviews: India slowdown to raise profitability challenges for pharma firms in Q1

Data from pharmaceutical market research company AIOCD Pharmasofttech AWACS Pvt. Ltd shows that growth in the country's pharmaceutical ...
Read more: India slowdown to raise profitability challenges for pharma firms in Q1

Pharma Reviews: Sudip Bandyopadhyay on what to buy in financials & pharma space

Sun Pharma and some of the other largecap pharma companies probably ... What strategy should one adopt vis-a-vis pharma sector? ... The softness of the US market has been getting more than adequately compensated by Indian ...
Read more: Sudip Bandyopadhyay on what to buy in financials & pharma space

Pharma Reviews: Five reasons why Morgan Stanley has turned bullish on Sun Pharma

The brokerage firm said Sun Pharma was its top pick in its Indian healthcare coverage and sees 27 per cent upside in the stock. The brokerage firm ...
Read more: Five reasons why Morgan Stanley has turned bullish on Sun Pharma

Pharma Reviews: Stocks in the news: Infosys, Allahabad Bank, DHFL, SBI, Jet and Sun Pharma

SBI: The market regulator has questioned State Bank of India over its failure to comply with new corporate governance norms, a situation that's arisen ...
Read more: Stocks in the news: Infosys, Allahabad Bank, DHFL, SBI, Jet and Sun Pharma

US FDA News: Statement on the agency’s actions to tackle the epidemic of youth vaping and court ruling on application submission deadlines for certain tobacco products, including e-cigarettes

FDA issues statement on actions to tackle youth vaping epidemic and court ruling on application deadlines for certain tobacco products, including e-cigarettes
Read more: Statement on the agency’s actions to tackle the epidemic of youth vaping and court ruling on application submission deadlines for certain tobacco products, including e-cigarettes

Pharma Reviews: Drug major GSK sold off up to 10 tail-end brands in FY19 including Celin

Vitamin manufacturing in India is largely dependent on import of active pharmaceutical ingredients (APIs) from China. Fluctuations in the prices of API ...
Read more: Drug major GSK sold off up to 10 tail-end brands in FY19 including Celin

Pharma Reviews: Man who hates fame

“Business journalists, investors, pharma industry and the world of finance know ... generic drug firm globally and one of the most valuable Indian enterprises, ... asking whether I wanted to discuss a book on Sun Pharma or Shanghvi.
Read more: Man who hates fame

Pharma Reviews: Pharma sector to post double-digit revenue Q1 growth: Analysts

Mumbai: India's top drug companies are likely to end a period of slow growth, with analysts predicting a double-digit revenue expansion for the ...
Read more: Pharma sector to post double-digit revenue Q1 growth: Analysts

Pharma Reviews: Opening Indian pharma's Bottle of Lies

The book, which has created quite a storm in the Indian pharmaceutical industry ever since its launch in the US in May, hit the stands in India in recent ...
Read more: Opening Indian pharma's Bottle of Lies

Pharma Reviews: After stents and knee implants, Modi govt wants to control prices of all medical devices

According to the Association of Indian Medical Device Industry (AIMED), the largest lobby of medical device makers in India, the sector is worth over ...
Read more: After stents and knee implants, Modi govt wants to control prices of all medical devices

Pharma Reviews: 'Bottle of Lies' review: 'Pharma Cos often make their worst drugs … for least regulated markets ...

In March 2013, US Food and Drug Administration investigator Peter Baker made a startling discovery in a large Indian pharmaceutical company's ...
Read more: 'Bottle of Lies' review: 'Pharma Cos often make their worst drugs … for least regulated markets ...

Pharma Reviews: Export-focused pharma cos need to improve compliance: Report

The US-focused domestic pharma companies need to step up regulatory ... points for commercial success, an India Ratings report said Wednesday.
Read more: Export-focused pharma cos need to improve compliance: Report

Pharma Reviews: From low-cost cures to busting deadly bugs, Gagandeep Kang, public-health crusader, has done it all

This April, Kang was named a Fellow of the Royal Society, the first Indian ... Kang tells ET Prime that the Indian pharma industry had progressed well ...
Read more: From low-cost cures to busting deadly bugs, Gagandeep Kang, public-health crusader, has done it all

Pharma Reviews: Diversify export basket to push India-Indonesia trade: Goyal

The Commerce & Industry said that there is considerable potential for ... cooperation on health and pharma sector between India and Indonesia.
Read more: Diversify export basket to push India-Indonesia trade: Goyal

Pharma Reviews: Commerce & Industry Minister holds bilateral talks with Indonesian Trade Minister

Indonesia has imported pharma products worth USD 990 million and India's share in their import was only USD 75 million. The Commerce & Industry ...
Read more: Commerce & Industry Minister holds bilateral talks with Indonesian Trade Minister

Pharma Reviews: India and Indonesia need to work towards sustainable trade: Piyush Goyal

New Delhi:Union Minister of Commerce & Industry and Railways, Piyush ... cooperation on health and pharma sector between India and Indonesia.
Read more: India and Indonesia need to work towards sustainable trade: Piyush Goyal

Pharma Reviews: Indian pharma market growth cools off to 7.9% in Q1 FY20

The growth of the Indian pharmaceutical market (IPM) moderated to 7.9 percent in the first quarter of FY20, with sluggish sales across most therapeutic ...
Read more: Indian pharma market growth cools off to 7.9% in Q1 FY20

Pharma Reviews: Market Live: Sensex off day's low, down 100 pts; Pharma, Realty indices outperform

India's retail inflation likely reached an eight-month high in June on rising food prices, but stayed under the Reserve Bank of India's medium-term ...
Read more: Market Live: Sensex off day's low, down 100 pts; Pharma, Realty indices outperform

Pharma Reviews: Titan's Fall Offsets Rally In Sun Pharma, Bajaj Finance As Sensex, Nifty Flat

Indian equity benchmarks ended little changed as the gains in Bajaj Finance Ltd. and Sun Pharmaceutical Industries Ltd. were offset by losses in Titan ...
Read more: Titan's Fall Offsets Rally In Sun Pharma, Bajaj Finance As Sensex, Nifty Flat

Pharma Reviews: No booster shot for pharma and biotech

There was nothing to fuel growth in the healthcare and pharma sectors, ... Ram Kaundinya, DG, Federation of Seed Industry of India, felt the Budget ...
Read more: No booster shot for pharma and biotech

Pharma Reviews: Watch: The Dark Underbelly of Generic Drugs & Fall of Ranbaxy

The US Food and Drug Administration had opened the gates for generic drug makers to enter American soil. Ranbaxy was the first Indian company to ...
Read more: Watch: The Dark Underbelly of Generic Drugs & Fall of Ranbaxy

Pharma Reviews: Sun Pharma Share Price Live: Sun Pharma Falls by 3.09% as Finance Minister Announces Union ...

Indian Pharmaceutical Alliance (IPA) last month said that the pharmaceutical sector in the country is aiming to grow to the size of $120-130 billion by ...
Read more: Sun Pharma Share Price Live: Sun Pharma Falls by 3.09% as Finance Minister Announces Union ...

Pharma Reviews: Nothing to fuel growth in healthcare, pharma sectors: Dr Reddy's

Nothing to fuel growth in healthcare, pharma sectors: Dr Reddy's ... is a missed opportunity, said Indian IT industry apex body Nasscom on Friday.
Read more: Nothing to fuel growth in healthcare, pharma sectors: Dr Reddy's

Pharma Reviews: Indian pharma industry to grow at 11-13 percent in FY2020, says rating agency Icra

“The growth trajectory for the Indian pharmaceutical industry is likely to remain at 11-13 per cent in FY2020, on the back of healthy demand from the ...
Read more: Indian pharma industry to grow at 11-13 percent in FY2020, says rating agency Icra

Pharma Reviews: Analyst Calls: Whirlpool,Jubilant Food, Bharti Infratel, Torrent Pharma, Tata Steel

The domestic stock market on Friday showed early signs of a possible ... Torrent Pharma's expanded revenue base in India helped the company ...
Read more: Analyst Calls: Whirlpool,Jubilant Food, Bharti Infratel, Torrent Pharma, Tata Steel

Pharma Reviews: Indian pharma industry to grow at 11-13 pc in FY2020: Icra

"The growth trajectory for the Indian pharmaceutical industry is likely to remain at 11-13 per cent in FY2020, on the back of healthy demand from the ...
Read more: Indian pharma industry to grow at 11-13 pc in FY2020: Icra

Pharma Reviews: 10 things you need to know before the opening bell on July 5

Investors await the government's proposals to revive India's economic .... 10. Indian Pharma Industry Growth: Indian pharmaceutical industry is likely to ...
Read more: 10 things you need to know before the opening bell on July 5

Pharma Reviews: 10 things you need to know before the opening bell on July 5

Indian shares are likely to open little changed on Friday amid caution .... 10. Indian Pharma Industry Growth: Indian pharmaceutical industry is likely to ...
Read more: 10 things you need to know before the opening bell on July 5

Pharma Reviews: Indian pharma industry to grow at 11-13 per cent in FY2020: Icra

New Delhi: Indian pharmaceutical industry is likely to grow by 11-13 per cent in the current fiscal, rating agency Icra said on Thursday. "The growth ...
Read more: Indian pharma industry to grow at 11-13 per cent in FY2020: Icra

Pharma Reviews: Indian pharma industry to grow at 11-13 pc in FY2020: Icra

Indian pharmaceutical industry is likely to grow by 11-13 per cent in the current fiscal, rating agency Icra said on Thursday. "The growth trajectory for ...
Read more: Indian pharma industry to grow at 11-13 pc in FY2020: Icra

Pharma Reviews: Job Series (Part 4): How Indian pharma companies are helping aspirants get employed

As NDA 2 gears up for its first Union Budget, all eyes will be on first-time Finance Minister Nirmala Sitharaman. She has her plate full, laden with ...
Read more: Job Series (Part 4): How Indian pharma companies are helping aspirants get employed

Pharma Reviews: Investments in R&D need go up to 2% of GDP: VK Saraswat

He said the Indian pharma sector is facing issues with regards to reverse engineering and IP rights of some drugs in USA and the government is in ...
Read more: Investments in R&D need go up to 2% of GDP: VK Saraswat

Pharma Reviews: Exploring the underlying opportunity in the Indian warehousing sector

A plethora of factors are driving this wave of change such as: requirement from compliance regulators (in case of the pharma industry), quality ...
Read more: Exploring the underlying opportunity in the Indian warehousing sector

Pharma Reviews: Pharma funds remain in poor health amid headwinds on compliance

India's pharma industry remains broadly impacted by the American and Indian market dynamics, with both having seen divergent trends, according to ...
Read more: Pharma funds remain in poor health amid headwinds on compliance

Pharma Reviews: Expectations from Union Budget 2019

"The pharma sector could be incentivized in the budget for adopting global practices & standards ... Ministry of Commerce and Industry, Government of India, CII, FICCI, ASSOCHAM, FIEO, IMC, APEDA, Spices Board, IIP and BIS.
Read more: Expectations from Union Budget 2019

Pharma Reviews: India: India's Appetite For Processed Fish Food Grows Stronger

India is one of the world's largest fish producers and top exporter of fish and fish ... The Indian seafood industry is an important sector of food production, ... Pharma Limited is an Indian pharmaceutical manufacturing company.
Read more: India: India's Appetite For Processed Fish Food Grows Stronger

Product Recall Alerts: 40 drugs, devices recalled this year

Here are 40 drugs, devices that have been recalled in 2019, beginning with the most ... March 18: Mylan recalls an injectable medication after potentially ... 1: Styker alerts customers of its Lifepak 15 to an issue that may cause the ...
Read more: 40 drugs, devices recalled this year

Pharma Reviews: Ensuring access to medicines in East Africa: Lessons from India

The final section of the paper examines the successes of India's pharmaceutical industry in specific states and concludes with an exploration of what ...
Read more: Ensuring access to medicines in East Africa: Lessons from India

Pharma Reviews: Telangana govt eyes $100-billion life sciences, pharma industry

With 800 plus pharma, biotech and medical technology companies in the state, ... Nagappan, who is also the CEO of Hyderabad Pharma City Ltd, ... Dr Prasanna Deshpande, deputy managing director, Indian Immunologicals Ltd ...
Read more: Telangana govt eyes $100-billion life sciences, pharma industry

Pharma Reviews: Market LIVE: Sensex, Nifty edge higher; Pharma, metal, auto stocks drag

Indian benchmark indices, BSE Sensex and NSE Nifty50, traded volatile after mildly positive on Wednesday amid hopes that the government could ...
Read more: Market LIVE: Sensex, Nifty edge higher; Pharma, metal, auto stocks drag

Pharma Reviews: Union Budget 2019: Pharma industry needs a dose of incentives to stay healthy

There is little doubt in the potential of the Indian pharmaceutical and healthcare industry to contribute to national growth and its need for quicker, ...
Read more: Union Budget 2019: Pharma industry needs a dose of incentives to stay healthy

Pharma Reviews: Dachser India receives IATA CEIV Pharma certification

"Congratulations to Dachser India on their CEIV Pharma certification. The time and temperature sensitive nature of pharmaceutical products means ...
Read more: Dachser India receives IATA CEIV Pharma certification

Pharma Reviews: Budget 2019: Pharma sector seeks revival of R&D tax breaks, sops for bulk drug investments

The Indian pharmaceutical industry expects the government to restore the tax benefit offered on research and development expenditure in the ...
Read more: Budget 2019: Pharma sector seeks revival of R&D tax breaks, sops for bulk drug investments

Pharma Reviews: BT Buzz: Can India gain from US-China trade war?

India's processed food exporters are trying to reach out to US retail chains like Walmart and CostCo, while Indian pharmaceutical companies ...
Read more: BT Buzz: Can India gain from US-China trade war?